Sunday, October 25, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,414 +0.17%ETH $2,343.72 +0.28%SOL $101.54 +0.33%XRP $1.30 +0.66%BNB $739.76 +1.16%DOGE $0.0771 +0.10%Prices: CoinGecko,
Back
Markets

Zymeworks Presents Phase 1 ZW191 Activity in Resistant Ovarian Cancer

By John Kim for TokenPost

Image: TokenPost

The heavily pretreated study population had platinum-resistant disease. The response-rate analysis focused on high-grade serous ovarian cancer.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories